Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline in MSA-P
NCT00977665Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2009
- Primary completion
- Oct 2011
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 12
01
Overview
A Phase 2 trial of rasagiline in multiple system atrophy (MSA), sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2009; status: completed.
02
Drugs
rasagiline
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT00977665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00977665.